The Latest Breaking News on Pharma

A "game-changing" drug that hit the Pharmaceutical Benefits Scheme (PBS) last week has already helped Newcastle's Carters family, the first in Australia to trial a weekly growth hormone injection called Ngenla.

A select list of stories to read before you start your day

BioNTech has stuck an in-principle partnership with the Victorian government to establish an mRNA manufacturing facility in Melbourne.

The mounting economic toll of China's zero-COVID policy is raising investor hopes that Beijing may finally begin laying the groundwork for the tricky epidemiological and political task of shifting course following this month's Communist Party congress.

The World Health Organisation says the contaminated medications may have been distributed outside of the West African country, and global exposure could well be ‘possible’.

Officials note that risk of Ebola outbreak in US remains low and no cases have been confirmed outside Uganda.

Favorable federal investments are anticipated to fuel further expansion in the biotech industry. Given the sector’s good prospects, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and Biogen (BIIB) could be ideal buys. However, fundamentally weak stock Intra-Cellular Therapies (ITCI) might be best avoided. Read on….

A new COVID-19 wave appears to be brewing in Europe as cooler weather arrives, with public health experts warning that vaccine fatigue and confusion over types of available vaccines will likely limit booster uptake.

The Biden administration says the United States will begin screening travelers coming from Uganda for Ebola as an additional precaution aimed at trying to prevent an outbreak in the African country from spreading

The UK Health Security Agency is currently monitoring an outbreak of the Ebola virus in Uganda - but the risk to the public in the UK is very low and there are currently no cases of the disease confirmed in this country

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of Radiation-Related Disorders."